Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative continuous esketamine infusion for pain after arthroscopic rotator cuff repair
ChiCTR2500101950Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain and Rotator cuff deficiency (RCD) (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Incidence of NRS-R score >= 4 within 48 hours. Started May 2025; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative painRotator cuff deficiency (RCD)
Beyond the preview
Go deeper on ChiCTR2500101950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101950.